196 related articles for article (PubMed ID: 31746436)
1. iTRAQ‑based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells.
Xu Y; Li X; Su X
Oncol Rep; 2020 Jan; 43(1):201-217. PubMed ID: 31746436
[TBL] [Abstract][Full Text] [Related]
2. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
3. New bioactive peptide reduces the toxicity of chemotherapy drugs and increases drug sensitivity.
Li X; Wu H; Ouyang X; Zhang B; Su X
Oncol Rep; 2017 Jul; 38(1):129-140. PubMed ID: 28560442
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects of β-elemene in gastric cancer cells and its potential underlying proteins: a proteomic study.
Liu JS; He SC; Zhang ZL; Chen R; Fan L; Qiu GL; Chang S; Li L; Che XM
Oncol Rep; 2014 Dec; 32(6):2635-47. PubMed ID: 25333415
[TBL] [Abstract][Full Text] [Related]
5. Selecting lncRNAs in gastric cancer cells for directed therapy with bioactive peptides and chemotherapy drugs.
Han W; Xiao R; Zhang C; Suyila Q; Li X; Su X
Oncotarget; 2017 Oct; 8(49):86082-86097. PubMed ID: 29156779
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of lysine acetylation proteins in gastric cancer treated with a new antitumor agent bioactive peptide chelate selenium.
Xu Y; Wen J; Han W; Yan J; Jia W; Su X
PeerJ; 2023; 11():e14384. PubMed ID: 36684675
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant stress and anticancer activity of peptide‑chelated selenium
Li X; Wang X; Liu G; Xu Y; Wu X; Yi R; Jin F; Sa C; Su X
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34165159
[TBL] [Abstract][Full Text] [Related]
8. ITRAQ-Based Proteomics Analysis of Triptolide On Human A549 Lung Adenocarcinoma Cells.
Li F; Zhao D; Yang S; Wang J; Liu Q; Jin X; Wang W
Cell Physiol Biochem; 2018; 45(3):917-934. PubMed ID: 29428961
[TBL] [Abstract][Full Text] [Related]
9. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells.
Mori R; Yoshida K; Tanahashi T; Yawata K; Kato J; Okumura N; Tsutani Y; Okada M; Oue N; Yasui W
Gastric Cancer; 2013 Jul; 16(3):345-54. PubMed ID: 22968820
[TBL] [Abstract][Full Text] [Related]
10. P38 Signal Transduction Pathway Has More Cofactors on Apoptosis of SGC-7901 Gastric Cancer Cells Induced by Combination of Rutin and Oxaliplatin.
Li Q; Ren L; Zhang Y; Gu Z; Tan Q; Zhang T; Qin M; Chen S
Biomed Res Int; 2019; 2019():6407210. PubMed ID: 31781632
[TBL] [Abstract][Full Text] [Related]
11. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
12. Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation.
Lei D; Hong T; Li L; Chen L; Luo X; Wu Q; Liu Z
Oncol Lett; 2021 Feb; 21(2):101. PubMed ID: 33376534
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer.
Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J
J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic analysis uncovers potential biomarkers involved in the anticancer effect of Scutellarein in human gastric cancer cells.
Saralamma VVG; Vetrivel P; Lee HJ; Kim SM; Ha SE; Murugesan R; Kim EH; Heo JD; Kim GS
Oncol Rep; 2020 Sep; 44(3):939-958. PubMed ID: 32705238
[TBL] [Abstract][Full Text] [Related]
15. Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A).
Su LY; Xin HY; Liu YL; Zhang JL; Xin HW; Su XL
Tumour Biol; 2014 Oct; 35(10):10051-6. PubMed ID: 25015188
[TBL] [Abstract][Full Text] [Related]
16. Expression of immune regulatory factors, chemokines and growth factors in differentiated gastric cancer cells treated with an anticancer bioactive peptide combined with oxaliplatin.
Li X; Peng J; Su X
Mol Clin Oncol; 2024 Jan; 20(1):9. PubMed ID: 38125743
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
Arora N; Alsaied O; Dauer P; Majumder K; Modi S; Giri B; Dudeja V; Banerjee S; Von Hoff D; Saluja A
PLoS One; 2017; 12(2):e0171827. PubMed ID: 28192510
[TBL] [Abstract][Full Text] [Related]
18. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells.
Yu L; Yang L; An W; Su X
J Cell Biochem; 2014 Apr; 115(4):697-711. PubMed ID: 24214799
[TBL] [Abstract][Full Text] [Related]
19. Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study.
Yan GR; Zou FY; Dang BL; Zhang Y; Yu G; Liu X; He QY
Proteomics; 2012 Aug; 12(14):2391-9. PubMed ID: 22887948
[TBL] [Abstract][Full Text] [Related]
20. LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway.
Liu J; Fu XQ; Zhou W; Yu HG; Yu JP; Luo HS
World J Gastroenterol; 2011 Jan; 17(2):181-90. PubMed ID: 21245990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
